---
title: "ApicHope: Subsidiary's innovative drug APH03621 tablets approved for clinical trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262567296.md"
description: "ApicHope's wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Co., Ltd., has received clinical trial approval from the National Medical Products Administration for its innovative drug APH03621 tablets, and clinical trials will be conducted soon. This drug is a novel oral, non-peptide small molecule gonadotropin-releasing hormone receptor antagonist aimed at treating endometriosis. Currently, there are no approved oral small molecule GnRH antagonists in the domestic market. This approval will have little impact on the company's short-term financial condition and operating performance"
datetime: "2025-10-24T08:10:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262567296.md)
  - [en](https://longbridge.com/en/news/262567296.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262567296.md)
---

# ApicHope: Subsidiary's innovative drug APH03621 tablets approved for clinical trials

ApicHope announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the clinical trial application of its innovative drug APH03621 tablets, and has received the "Notice of Approval for Drug Clinical Trials." Clinical trials will commence shortly. APH03621 is a new oral, non-peptide small molecule gonadotropin-releasing hormone receptor antagonist developed by the company, intended for the treatment of endometriosis. Currently, there are no approved GnRH oral small molecule antagonists on the market in China. The approval of clinical trials for APH03621 tablets will not have a significant impact on the company's short-term financial condition or operating performance

### Related Stocks

- [300723.CN](https://longbridge.com/en/quote/300723.CN.md)

## Related News & Research

- [This Baby Name Is Tanking In Popularity. Are Politics To Blame?](https://longbridge.com/en/news/287208182.md)
- [Coffee Prices Rebound on Technical Short-Covering](https://longbridge.com/en/news/286941721.md)
- [Chase Stokes has sold his South Carolina home for $3 million after wrapping up final season of 'Outer Banks'](https://longbridge.com/en/news/287187868.md)
- [CEO.CA's Inside the Boardroom: How Viva Gold is Slashing Costs and De-Risking the Tonopah Gold Project in Nevada | VAUCF Stock News](https://longbridge.com/en/news/287236638.md)
- [Commentary: The football world will watch EPL’s streaming service debut in Singapore](https://longbridge.com/en/news/287277838.md)